We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLOW icon
176
Douglas Dynamics
PLOW
$984M
– –
-128,000
Closed -$3.77M
QCOM icon
177
Qualcomm
QCOM
$170B
– –
-13,557
Closed -$2.16M
RRX icon
178
Regal Rexnord
RRX
$11.5B
– –
-72,133
Closed -$10.5M
RYN icon
179
Rayonier
RYN
$6.52B
– –
-467,916
Closed -$9.9M
TXG icon
180
10x Genomics
TXG
$7.63B
– –
-236,064
Closed -$2.73M
U icon
181
Unity
U
$19B
– –
-489,191
Closed -$11.8M
VC icon
182
Visteon
VC
$2.8B
– –
-62,941
Closed -$5.87M
WEX icon
183
WEX
WEX
$6.35B
– –
-50,683
Closed -$7.44M
XPER icon
184
Xperi
XPER
$332M
– –
-247,955
Closed -$1.96M
ZBH icon
185
Zimmer Biomet
ZBH
$18.7B
– –
-89,088
Closed -$8.13M
MTUS icon
186
Metallus
MTUS
$900M
– –
-697,815
Closed -$10.8M
4 5 6 7
8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.